Industry
Jazz Pharma to present new research findings on Epidyolex
The company has shared new findings on its role in treating seizures related to rare forms of epilepsy.
Search
8 results for “dravet-syndrome”
Epilepsy
Dr Jen Anderson: “Helping other families access cannabis healed my own trauma”
Dr Jen Anderson, a paediatric prescriber of medical cannabis in Canada, shares her own journey.
Epilepsy
Scotland approves Epidyolex for tuberous sclerosis-related epilepsy
Epidyolex can now be prescribed on the NHS for epilepsy-related tuberous sclerosis complex (TSC).
Epilepsy
Study examines if CBGA has an effect on epileptic seizures
The study is the next stage in research examining the efficacy of different cannabinoids for treatment of Dravet Syndrome
Epilepsy
New CBD nasal spray to target seizures in epilepsy
The nasal spray will help the CBD to bypass the liver reducing concerns about drug interactions.
Industry
Spain approves first cannabis based medicine
The approval for Epidyolex was based on the results of four randomised controlled Phase III trials
Industry
Epidyolex gains approval for seizures associated with tuberous sclerosis complex
TSC can cause epilepsy in up to 85 percent of those with the condition and up to 60 percent do not respond to standard anti-seizure medicines.
Feature
CBD may reduce side effects associated with anti-seizure medications.
Could CBD help with the side effects of anti-seizure medications for people with epilepsy?